Education
About Us
Working with TipRanks
Follow Us
Solventum Corporation (SOLV)
:SOLV
SOLV Stock Chart & Stats
Day’s Range― - ―
52-Week Range$58.61 - $85.92
Previous CloseN/A
Volume531.14K
Average Volume (3M)683.97K
Market Cap
$12.69B
Enterprise Value$20.61B
Total Cash (Recent Filing)$492.00M
Total Debt (Recent Filing)$7.82B
Price to Earnings (P/E)33.7
Beta0.64
Next Earnings
Nov 06, 2025EPS Estimate
1.4Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)1.69
Shares Outstanding173,387,800
10 Day Avg. Volume954,808
30 Day Avg. Volume683,973
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.62
Enterprise Value/Revenue2.46
Enterprise Value/Gross Profit4.51
Enterprise Value/Ebitda16.15
Forecast
1Y Price Target
$89.33Price Target Upside22.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering9
Bulls Say, Bears Say
Bulls Say
Debt ManagementNet proceeds from the transaction are primarily intended to pay down debt.
EarningsAnalyst expects EPS to increase after retaining the Drinking Water Filtration business.
ValuationSOLV's shares are considered undervalued compared to similar companies, trading at a relatively low multiple, which suggests potential for price appreciation.
Bears Say
Margin PressureThe transaction is a headwind on Solventum's 200bps gross margin and 100bps operating margin targets due to lower margins in the purification and filtration business.
Market PositionSOLV shares trade below large-cap MedTech peers which possess a better growth and margin profile.
TariffsNotable headwinds include tariffs and a cost impact from its 3M supply contract.
Solventum Corporation News
SOLV FAQ
What was Solventum Corporation’s price range in the past 12 months?
Solventum Corporation lowest stock price was $58.61 and its highest was $85.92 in the past 12 months.
What is Solventum Corporation’s market cap?
Solventum Corporation’s market cap is $12.69B.
When is Solventum Corporation’s upcoming earnings report date?
Solventum Corporation’s upcoming earnings report date is Nov 06, 2025 which is in 82 days.
How were Solventum Corporation’s earnings last quarter?
Solventum Corporation released its earnings results on Aug 07, 2025. The company reported $1.69 earnings per share for the quarter, beating the consensus estimate of $1.45 by $0.24.
Is Solventum Corporation overvalued?
According to Wall Street analysts Solventum Corporation’s price is currently Undervalued.
Does Solventum Corporation pay dividends?
Solventum Corporation does not currently pay dividends.
What is Solventum Corporation’s EPS estimate?
Solventum Corporation’s EPS estimate is 1.4.
How many shares outstanding does Solventum Corporation have?
Solventum Corporation has 173,387,800 shares outstanding.
What happened to Solventum Corporation’s price movement after its last earnings report?
Solventum Corporation reported an EPS of $1.69 in its last earnings report, beating expectations of $1.45. Following the earnings report the stock price went up 2.001%.
Which hedge fund is a major shareholder of Solventum Corporation?
Currently, no hedge funds are holding shares in SOLV
Solventum Corporation Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$89.33 (22.04% Upside)
$89.33 (22.04% Upside)
Blogger Sentiment
Bullish
SOLV Sentiment 70%
Sector Average 74%
Sector Average 74%
Hedge Fund Trend
Increased
By 4.2M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days <0.1%
Last 30 Days ▼ 1.9%
Last 30 Days ▼ 1.9%
News Sentiment
Neutral
Bullish news 59%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
26.68%
12-Months-Change
Fundamentals
Return on Equity
11.64%
Trailing 12-Months
Asset Growth
3.40%
Trailing 12-Months
Company Description
Solventum Corporation
Solventum Corporation (SOLV) is a leading provider in the specialty chemicals sector, focusing on innovative solvent solutions for various industries, including pharmaceuticals, agriculture, and industrial manufacturing. The company specializes in developing high-performance solvents that enhance product efficiency and sustainability, catering to the growing demand for eco-friendly chemical alternatives. With a strong commitment to research and development, Solventum offers a diverse portfolio of products that meet the stringent regulatory standards of its global clientele.
SOLV Company Deck
SOLV Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call highlighted Solventum's positive sales growth, increased guidance, and successful operational changes, despite facing challenges such as product recalls and market pressures in certain segments. The company's recognition and strategic partnerships further emphasize its progress and positive outlook.View all SOLV earnings summariesSOLV Stock 12 Month Forecast
Average Price Target
$89.33
▲(22.04% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Encompass Health
―
Tenet Healthcare
―
Universal Health
―
Ownership Overview
0.10% Insiders
17.89% Mutual Funds
0.99% Other Institutional Investors
61.05% Public Companies and
Individual Investors